loadpatents
Patent applications and USPTO patent grants for IRLA; Magali.The latest application filed is for "methods of boosting thymic regeneration in patients suffering from a thymic injury by using rankl".
Patent | Date |
---|---|
Methods Of Boosting Thymic Regeneration In Patients Suffering From A Thymic Injury By Using Rankl App 20220265768 - IRLA; Magali ;   et al. | 2022-08-25 |
Regulatory T Cells Targeted By Lymphotoxin Alpha Blocking Agent And Uses Thereof App 20220259561 - IRLA; Magali | 2022-08-18 |
Methods of boosting thymic regeneration in patients suffering from a thymic injury by using RANKL Grant 11,351,226 - Irla , et al. June 7, 2 | 2022-06-07 |
Regulatory T Cells Genetically Modified For The Lymphotoxin Alpha Gene And Uses Thereof App 20200392456 - IRLA; Magali | 2020-12-17 |
Methods Of Boosting Thymic Regeneration In Patients Suffering From A Thymic Injury By Using Rankl App 20200009224 - IRLA; Magali ;   et al. | 2020-01-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.